Kristie-Ann Dickson

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Transcription Factor

Endometrial Cancer

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yue Ma, Natisha R Field, Tao Xie, Sarina Briscas, Emily G Kokinogoulis, Tali S Skipper, Amani Alghalayini, Farhana A Sarker, Nham Tran, Nikola A Bowden, Kristie-Ann Dickson, Deborah J Marsh
Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies-Therapeutic Vulnerabilities in Treatment-Resistant Subtypes. Cancers 16 (17) (2024)
Dongli Liu, Gunnar F Kaufmann, James B Breitmeyer, Kristie-Ann Dickson, Deborah J Marsh, Caroline Elizabeth Ford
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells. Pharmaceutics 14 (4) (2022)
Tao Xie, Kristie-Ann Dickson, Christine Yee, Yue Ma, Caroline Elizabeth Ford, Nikola A Bowden, Deborah J Marsh
Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival. Cancers 14 (19) (2022)
Nidhi Joshi, Dongli Liu, Kristie-Ann Dickson, Deborah J Marsh, Caroline E Ford, Martina M Stenzel
An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles. Journal of materials chemistry. B 9 (44) (2021)
Kristie-Ann Dickson, Tao Xie, Christian Evenhuis, Yue Ma, Deborah J Marsh
PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer. International journal of molecular sciences 22 (16) (2021)
Deborah J Marsh, Yue Ma, Kristie-Ann Dickson
Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer. Cancers 12 (11) (2020)
Deborah J Marsh, Kristie-Ann Dickson
Writing Histone Monoubiquitination in Human Malignancy-The Role of RING Finger E3 Ubiquitin Ligases. Genes 10 (1) (2019)